130
Participants
Start Date
March 9, 2021
Primary Completion Date
June 30, 2025
Study Completion Date
July 31, 2025
GEN3014
GEN3014 is administered by IV infusion.
Daratumumab
Daratumumab is administered by SC injections.
University Hospitals Cleveland Medical Center, Cleveland
Medical college of Wisconsin, Milwaukee
John Theurer Cancer Center, Hackensack
Northern Health, Epping
The Alfred Hospital, Melbourne
Royal Prince Alfred Hospital, Sydney
University Clinical Center of the Republic of the Srpska, Banja Luka
Klinika za hematologiju KCUS, Sarajevo
UKC - University Clinical Center Tuzla, Tuzla
Fakultni Nemocnice Brno, Brno
Vseobecna fakultni nemocnice, New Town
Fakultni Nemocnice Hradec Kralove FNHK, Nový Hradec Králové
Fakultni Nemocnice Olomouc (FNOL), Olomouc
FNO - Fakultni nemocnice Ostrava, Poruba
Aalborg Universitet, Aalborg
Vejle Hospital, Vejle
CHRU de Lille, Lille
CHRU de Nantes, Nantes
ARENSIA Exploratory Medicine LLC, Tbilisi
Alexandra General Hospital, Athens
Evangelismos Hospital NKUA, Athens
University General Hospital of Patras, Rio
Ahepa University General hospital, Thessaloniki
Szabolcs-Szatmar-Bereg County Hospitals and University Hospital, Josa Andras University Hospital, Nyíregyháza
Hospital Ampang, Ampang
Hospital Sultanah Aminah, Johor Bahru
Hospital Umum Sarawak, Kuching
Beacon Hospital, Petaling Jaya
Institute of Oncology, ARENSIA Exploratory Medicine, Chisinau
Maastricht UMC, Maastricht
Erasmus MC, Rotterdam
UMC Utrecht, Utrecht
Christchurch Hospital, Christchurch
Auckland Cancer Trials Centre, Grafton
Palmerston North Hospital, Palmerston North
North Shore Hospital, Takapuna
University Clinic of Hematology, Skopje
Makati Medical Center, Makati City
University Centrum Kliniczne, Gdansk
Pratia Onkologia Katowice, Katowice
Pratia MCM, Krakow
Wroclaw Medical University, Wroclaw
Chonnam National University Hwasun Hospital, Gwangju
Pusan National University Hospital PNUH, Pusan
Gachon University Gil Medical Center, Seongnam
Samsung Medical Center, Seoul
Seoul National University Hospital, Seoul
University of Navarra, Pamplona
University Hospital of Salamanca, Salamanca
Karolinska Institute, Huddinge
Universitetssjukhuset i Lund, Lund
Arensia Exploratory Medicine, Kyiv
Lead Sponsor
Genmab
INDUSTRY